Development of CDX-527: a bispecific antibody combining PD-1 blockade and CD27 costimulation for cancer immunotherapy
2020 · Cancer Immunology Immunotherapy · 29 citations
https://doi.org/10.1007/s00262-020-02610-y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Colleen Patterson is an academic researcher.
https://doi.org/10.1007/s00262-020-02610-y
https://doi.org/10.1016/j.jaci.2024.12.713
Click to start Chat